Measles Mumps Rubella

MMR uptake fell during early 2002 but is now recovering

Published in Vaccine Weekly, July 24th, 2002

Latest data show that measles mumps rubella (MMR) vaccine uptake in 16- and 24-month-old U.K. children fell over the winter period but then increased in April 2002. This dip was likely to be associated in large part with the intense adverse publicity about MMR over the Christmas and New Year period, which was around the time that the 16-month-old children were scheduled to receive their first dose of MMR.

Children are scheduled to receive their first dose of MMR at around 12-15 months of age. National routine monitoring of vaccination uptake normally takes place for children at ages 2 and 5 years. The latest routine data published for children age 2 years in the U.K....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-07-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry